Owens & Minor Ends Merger with Rotech Healthcare

Owens & Minor ( (OMI) ) has shared an update.

On June 3, 2025, Owens & Minor, Inc. and Rotech Healthcare Holdings Inc. mutually agreed to terminate their merger agreement, with Owens & Minor paying an $80 million termination fee to Rotech. The decision was influenced by regulatory challenges and the company will now focus on growing its Patient Direct business and deleveraging, while exploring potential sales of its Products and Healthcare Services business.

The most recent analyst rating on (OMI) stock is a Sell with a $7.00 price target. To see the full list of analyst forecasts on Owens & Minor stock, see the OMI Stock Forecast page.

Spark’s Take on OMI Stock

According to Spark, TipRanks’ AI Analyst, OMI is a Neutral.

Owens & Minor’s financial health is challenged by profitability issues and high leverage. The technical indicators suggest bearish sentiment. Despite strategic acquisitions and positive steps like debt reduction, the valuation remains low due to ongoing net losses.

To see Spark’s full report on OMI stock, click here.

More about Owens & Minor

Owens & Minor, Inc. is a Fortune 500 global healthcare solutions company that provides essential products and services supporting care from the hospital to the home. With over 100 years of experience, the company and its affiliated brands, such as Apria, Byram, and HALYARD, serve patients, providers, and communities worldwide.

Average Trading Volume: 1,383,230

Technical Sentiment Signal: Sell

Current Market Cap: $512.5M

For a thorough assessment of OMI stock, go to TipRanks’ Stock Analysis page.